BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Diagnosis
40 results:

  • 1. Impact of Commission on cancer Accreditation on cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
    Ahmed A; Whittington J; Shafaee Z
    Ann Surg Oncol; 2024 Apr; 31(4):2286-2294. PubMed ID: 38093167
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Exploration of the Perturbation of PKIG in lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method].
    Liu Q; Li H; Li B; Ren M; Li Z; Chen Y; Zheng Z; Meng Y; Feng H
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):523-537. PubMed ID: 37653016
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy.
    Liao KM; Wang JJ; Ho CH
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1057-1066. PubMed ID: 37309394
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of lung cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of lung Nodules in the Mississippi Delta.
    Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
    JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
    Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
    Front Immunol; 2022; 13():918254. PubMed ID: 36466914
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The diagnostic value of has_circ_0006423 in non-small cell lung cancer and its role as a tumor suppressor gene that sponges miR-492.
    Zhu L; Sun L; Xu G; Song J; Hu B; Fang Z; Dan Y; Li N; Shao G
    Sci Rep; 2022 Aug; 12(1):13722. PubMed ID: 35962012
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Changes in Survival Outcomes of Patients With Neuroendocrine Neoplasms Over the Past 15 Years: A Real-World Study.
    Abdel-Rahman O; Pham TM; Pokhrel A; Ruether D; Sawyer MB
    Am J Clin Oncol; 2022 May; 45(5):208-214. PubMed ID: 35383575
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of Smoking With Patient Characteristics and Outcomes in Small Cell lung Carcinoma, 2011-2018.
    Tseng JS; Chiang CJ; Chen KC; Zheng ZR; Yang TY; Lee WC; Hsu KH; Huang YH; Liu TW; Hsia JY; Chang GC
    JAMA Netw Open; 2022 Mar; 5(3):e224830. PubMed ID: 35353165
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Improvement in lung cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016.
    Bogos K; Kiss Z; Tamási L; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Daniel A; Vokó Z; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Barcza Z; Gálffy G; Moldvay J
    Pathol Oncol Res; 2021; 27():603937. PubMed ID: 34257563
    [No Abstract]    [Full Text] [Related]  

  • 10. Cell-Free DNA to Detect Heart Allograft Acute Rejection.
    Agbor-Enoh S; Shah P; Tunc I; Hsu S; Russell S; Feller E; Shah K; Rodrigo ME; Najjar SS; Kong H; Pirooznia M; Fideli U; Bikineyeva A; Marishta A; Bhatti K; Yang Y; Mutebi C; Yu K; Kyoo Jang M; Marboe C; Berry GJ; Valantine HA;
    Circulation; 2021 Mar; 143(12):1184-1197. PubMed ID: 33435695
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Real-World Treatment Patterns and Progression-Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non-Small Cell lung cancer.
    Jahanzeb M; Lin HM; Pan X; Yin Y; Wu Y; Nordstrom B; Socinski MA
    Oncologist; 2020 Oct; 25(10):867-877. PubMed ID: 32490560
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association between cancer-specific adverse event triggers and mortality: A validation study.
    Weingart SN; Nelson J; Koethe B; Yaghi O; Dunning S; Feldman A; Kent D; Lipitz-Snyderman A
    Cancer Med; 2020 Jun; 9(12):4447-4459. PubMed ID: 32285614
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pulmonary and overall healthcare utilization after childhood and young adult thyroid cancer.
    Di Giuseppe G; Zuk AM; Wasserman JD; Pole JD
    Endocr Relat Cancer; 2020 Jun; 27(6):391-402. PubMed ID: 32252026
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Results of the spanish section of the European Randomized Study of Screening for Prostate cancer (ERSPC). Update after 21 years of follow-up.
    Luján Galán M; Páez Borda Á; Llanes González L; Romero Cajigal I; Berenguer Sánchez A
    Actas Urol Esp (Engl Ed); 2020; 44(6):430-436. PubMed ID: 32147352
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The incidence of skip metastases on whole bone MRI in high-grade bone sarcomas.
    Saifuddin A; Sharif B; Oliveira I; Kalus S; Barnett J; Pressney I
    Skeletal Radiol; 2020 Jun; 49(6):945-954. PubMed ID: 31919587
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Advanced Pneumonic-type lung Carcinoma: A Retrospective Study of Clinical-radiological-pathological Characteristics with Survival Analysis in A Single Chinese Hospital].
    Liu Y; Li J; Wang S; Chen M; Zhao J; Jiang D; Zhong W; Xu Y; Wang M
    Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):329-335. PubMed ID: 31196365
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Familial Urinary Bladder cancer with Other cancers.
    Yu H; Hemminki O; Försti A; Sundquist K; Hemminki K
    Eur Urol Oncol; 2018 Dec; 1(6):461-466. PubMed ID: 31158089
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The contribution of second primary cancers to the mortality of patients with a gastric first primary cancer.
    Morais S; Antunes L; Bento MJ; Lunet N
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):471-477. PubMed ID: 30601339
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations.
    Lam VK; Tran HT; Banks KC; Lanman RB; Rinsurongkawong W; Peled N; Lewis J; Lee JJ; Roth J; Roarty EB; Swisher S; Talasaz A; Futreal PA; Papadimitrakopoulou V; Heymach JV; Zhang J
    Clin Lung Cancer; 2019 Jan; 20(1):30-36.e3. PubMed ID: 30279110
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Incidence of Diabetes After cancer Development: A Korean National Cohort Study.
    Hwangbo Y; Kang D; Kang M; Kim S; Lee EK; Kim YA; Chang YJ; Choi KS; Jung SY; Woo SM; Ahn JS; Sim SH; Hong YS; Pastor-Barriuso R; Guallar E; Lee ES; Kong SY; Cho J
    JAMA Oncol; 2018 Aug; 4(8):1099-1105. PubMed ID: 29879271
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.